Effect of <it>KRAS</it> codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group

Effect of <it>KRAS</it> codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group

<p>Abstract</p> <p>Background</p> <p>To evaluate the value of <it>KRAS</it> codon 13 mutations in patients with advanced colorectal cancer (advanced CRC) treated with oxaliplatin and fluoropyrimidines.</p> <p>Methods</p> <p>Tumor spec...

Full description

Bibliographic Details
Main Authors: Reinacher-Schick Anke, Schulmann Karsten, Modest Dominik P, Bruns Nina, Graeven Ulrich, Jaworska Malgorzata, Greil Richard, Porschen Rainer, Arnold Dirk, Schmiegel Wolff, Tannapfel Andrea
Format: Article
Language:English
Published: BMC 2012-08-01
Series:BMC Cancer
Subjects:
Codon 13 mutation
Colorectal cancer
<it>KRAS</it>
Oxaliplatin
Prognosis
Online Access:http://www.biomedcentral.com/1471-2407/12/349

Internet

http://www.biomedcentral.com/1471-2407/12/349

Similar Items